Zusammenfassung
Die Krankheiten des Herz-Kreislauf-Systems stellen unverändert die Todesursache Nummer eins dar. 1994 starben in Deutschland — nach Angaben des statistischen Bundesamtes — von 100 000 Einwohnern (Männern bzw. Frauen) 449 Männer und 601 Frauen an einer Erkankung des Kreislaufsystems, darunter 123 Männer und 91 Frauen an den Folgen eines akuten Myokardinfarktes. Da Behandlungsmaßnahmen den individuellen Krankheitsverlauf bei kardiovaskulären Erkrankungen entscheidend beeinflussen können, ist es wichtig, die Individuen zu identifizieren, die an einer KHK erkrankt sind, um durch effektive Therapiemaßnahmen (Eliminierung der Risikofaktoren, medikamentöse Therapie, ggf. Revaskularisation) Krankheitsverlauf und Prognose zu verbessern.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Gleichmann A, Mannebach H, Lichtlen P (1995) 10. Bericht über Struktur und Leistungszahlen der Herzkatheterlabors in der Bundesrepublik Deutschland. Z Kardiol 84: 327–330.
Hanrath P, Meyer J (1995) Anhang der Kommission für Klinische Kardiologie zum 10. Bericht über Struktur und Leistungszahlen der Herzkatheterlabors in der Bundesrepublik Deutschland. Z Kardiol 84: 330–332.
Fischman DL, Leon MB, Bairn DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Ciernan M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S, for the Stent Restenosis Study Investigators (1994) A randomized comparison of coronary-stent placement and ballon angioplasty in the treatment of coronary artery disease. N Engl J Med 331: 496–501.
Serruys PW, De Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand A, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, Van Den Heuvel P, Dekan JD, Morel MA, for the Benestent Study Group (1994) A comparison of ballon-expandable-stent implantation with ballon angioplasty in patients with coronary artery disease. N Engl J Med 331: 489–495.
Cohen DJ, Krumholz HM, Sukin CA, Kalon KL, Siegrist RB, Ciernan M, Heuser RR, Brinker JA, Moses JW, Savage MP, Detre K, Leon MB, Bairn DS, for the Stent Restenosis Study Investigators (1995) In-hospital and one-year economic outcomes after coronary stenting or ballon angioplasty, results from a randomized clinical trial. Circulation 92: 2480–2487.
Eeckhout E, Kappenberger L, Goy JJ (1996) Stents for intracoronary placement: current status and future directions. J Am Coll Cardiol 27: 757–765.
Schartl M, Beckmann S, Bocksch W (1994) Streßechokardiographie -eine Standortbestimmung. Z Kardiol 83: 531–547.
Schicha H, Voth E (1994) Qualitätssicherung in der Kardiologie: Nuklearmedizin. Z Kardiol 83 (Suppl 6): 27–36.
Ritchie JL, Bateman TM, Bonow RO, Crawford MH, Gibbons RJ, Hall RJ, O’Rourke RA, Parisi AF, Verani MS (1995) Guidelines for clinical use of cardiac radionuclide imaging. Rep American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Comittee on Radionuclide Imaging), developed in collaboration with the American Society of Nuclear Cardiology. J Am Coll Cardiol 25: 521–547.
Diamond AG, Forrester JS (1979) Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 300:1350–1358.
Nicolaides AN (1985) The diagnosis and assessment of coronary artery disease in vascular patients. J Vase Surg 2: 501–505.
Tomatis LA, Fierens EE, Verbrugge GP (1972) Evaluation of surgical risk in peripheral vascular disease by coronary arteriography. Surgery 71: 429–435.
Shaw LJ, Eagle KA, Gersh BJ, Miller DM (1996) Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985–1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery. J Am Coll Cardiol 27: 787–798.
Goldman L (1996) Cardiac risk for vascular surgery, editorial comment. J Am Coll Cardiol 27: 799–802.
Heusch G, Schulz R (1993) Chronische Myokardischämie - Hibernating Myocardium: Merkmale und Grenzen. Z Kardiol 82, (Suppl 5): 133–141.
Erdmann E, Kirsch CM (1993) „Stunned" und „Hibernating myocardium" - Diagnostik und klinische Implikationen. Z Kardiol 82 (Suppl 5): 143–147.
Heusch G, Schulz R (1995) Pathophysiologic des „hibernating" und „stunned" Myokards, aus: Interventionen am Herzen, Springer, Berlin Heidelberg New York, S 367–383.
Dilsizian V, Bonow RO (1993) Current diagnostic techniques of assessing myocardial viability in hibernating and stunned myocardium. Circulation 87:1–20.
Rahimtoola SH (1985) A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 72 (Suppl V): V123–V125.
Rahimtoola SH (1989) The hibernating myocardium. Am Heart J 117: 211–212.
Braunwald E, Kloner RA (1982) The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 83: 26–37.
Tamaki N, Kawamoto M, Tadamura E, Magata Y, Yonekura Y, Nohara R, Sasayama S, Nishimura K, Ban T, Konishi J (1995) Prediction of reversible ischemia after revascularisation, perfusion and metabolic studies with positron emission tomography. Circulation 91:1697–1705.
Schneider CA, Voth E, Theissen P, Wienhard K, Wagner R, Baer FM, Sechtem U, Schicha H (1994) Vitalitätsbeurteilung chronischer Myokardinfarkte durch 18F-Fluro-D-Glukose-Posi-tronenemissionstomographie und 99mTc-MIBI-SPECT. Z Kardiol 93:124–131.
Sawada SG, Allman KC, Muzik O, Beanlands RSB, Wolfe ER, Gross M, Fig L, Schwaiger M (1994) Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol 23: 92–98.
Patterson RE, Eisner RL, Horowitz SF (1995) Comparison of cost-effectiveness and utility of exercise ecg, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease. Circulation 91: 54–65.
Brunken R, Schwaiger M, Grover-McKay M, Phelps M, Tillisch J, Schelbert H (1987) Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol 10: 557–567.
Dilsizian V, Bonow R (1993) Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 87:1–20.
Kiat H, Berman DS, Maddahi J et al. (1988) Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability. J Am Coll Cardiol 12:1456–1463.
Dilsizian V, Rocco TP, Freedmann NMT, Leon MB, Bonow RO (1990) Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 323:141–146.
Othani H, Tamaki N, Yonekura Y, Mohiuddin IH, Hirata K, Ban T, Konishi J (1990) Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 66: 394–399.
Crane P, Laliberte R, Hemingway S, Thoolen M, Orlandi C (1993) Effect of mitochondrial viability and metabolism on technetium-99m sestamibi myocardial retention. Eur J Nucl Med 20: 20–25.
Sinusas AJ, Watson DD, Cannon JM, Beller GA (1989) Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201. J Am Coll Cardiol 14:1785–1793.
Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Triamarco B, Salvatore M (1992) Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. J Nucl Med 33: 505–511.
Marzullo P, Sambuceti G, Parodi O (1992) The role of sestamibi scintigraphy in radioisotopic assessment of myocardial viability. J Nucl Med 33:1925–1930.
Sawada SG, Allmann KC, Muzik O, Beanlands RSB, Edwin R, Wolfe ER, Gross M, Fig L, Schwaiger M (1994) Positron emission tomography detects evidence of viability in rest tech-netium-99m sestamibi defects. J Am Coll Cardiol 23: 92–98.
Dilsizian V, Arrighi JA, Diodati JG et al. (1994) Myocardial viability in patients with chronic ischemic left ventricular dysfunction: comparison of 99mTc-sestambi, 201Thallium, and 18F-fluorodeoxyglucose. Circulation 89: 578–587.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bickel, C. (1997). Erwartungen des Kardiologen an die SPECT-Untersuchung des Herzens. In: Wieler, H.J. (eds) Single-Photon-Emissions-Computertomographie (SPECT) des Herzens. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60621-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-60621-2_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64479-5
Online ISBN: 978-3-642-60621-2
eBook Packages: Springer Book Archive